Loading...
Real-World Clinical Application of 12-Week Sofosbuvir/Velpatasvir Treatment for Decompensated Cirrhotic Patients with Genotype 1 and 2: A Prospective, Multicenter Study
INTRODUCTION: Clinical trials of direct-acting antivirals for patients with decompensated cirrhosis have been conducted, but there is limited information on the medicinal applications in clinical settings. We aimed to evaluate the safety and efficacy of sofosbuvir/velpatasvir for decompensated cirrh...
Na minha lista:
| Udgivet i: | Infect Dis Ther |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Springer Healthcare
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7680481/ https://ncbi.nlm.nih.gov/pubmed/32897520 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40121-020-00329-y |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|